Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends

Mar 09 2018

• By Mandy Jackson

Finance Watch

Related Content

Sage's Oral GABA-A Modulator Shows 'Dramatic' Effect On Depression

Dec 08 2017

US IPOs In Review: Relatively Muted Market In 2016 To Continue In 2017

Dec 31 2016

Finance Watch: Canaan Closes New VC Fund; CARB-X Backs More Antibiotics

Aug 02 2017

Arix To Nurture Next Generation Biotechs After UK IPO

Feb 03 2017

All Smiles At Sage As Phase III Postpartum Depression Data Are Positive

Nov 09 2017

Finance Watch: A Bountiful November Harvest For Venture-Backed Biopharma

Nov 21 2017

Video Interview: TLC Delivers Sustained Release And Improved Tissue Targeting

Mar 03 2016

Antibiotic Pipeline Profile: Targeting Delivery To Infection Site

Jul 07 2017

Heplisav-B Approval Has Dynavax Going It Alone On US Launch In Early 2018

Nov 13 2017

Autolus Raises $80m To Take T-Cell Engineering To The Next Level

Sep 26 2017

Takeda seeks 'big data' analytics for rare disease drug discovery

Apr 10 2015

Biotech VC dips in 3Q, but 2014 on track to beat 2013

Oct 27 2014

Allergan Relying On 'Six Stars' And Other R&D Programs To Blunt Restasis Blow

Jan 19 2018

Celgene Seeks CAR-T Leadership, Hematology Diversification With Juno Buy

Jan 23 2018

Pipeline Watch: Phase III Progress With Avelumab, Ixekizumab And Eravacycline

Feb 16 2018

Closer To Home: Hong Kong Takes On Nasdaq For China Biotech IPOs

Feb 06 2018

IPO Update: Seven In January As Big Returns, Solid's Slip-Up Contribute To Bubble Concerns

Feb 02 2018

Acacia's Euronext Listing To Help Target Unmet US PONV Market

Feb 05 2018

Finance Watch: Another Mega-Round As Moderna Bucks Biopharma's IPO Trend

Feb 05 2018

Incentives, Novel Tech Seen Driving Multiple Korean IPOs In 2018

Feb 07 2018

Aimmune Accelerates Commercial Planning For Peanut Allergy Drug

Feb 21 2018

Unum Therapeutics Inc.

May 25 2015

Venture Funding Deals, July 2015

Jul 09 2015

FDA Reversal Gives Amicus Renewed Hope For US Oral Fabry Launch

Jul 11 2017

Related Companies

Dermapharm AG

Acacia Pharma Group plc

Evolus, Inc.

Allergan plc

Biofrontera AG

PolyPid Ltd.

Takeda Pharmaceutical Co. Ltd.

Arcus Biosciences, Inc.

Taiwan Liposome Company, Ltd.

Cogent Biosciences, Inc.

Homology Medicines, Inc.

Autolus Therapeutics plc

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Sage Therapeutics, Inc.

Amicus Therapeutics, Inc.

Aimmune Therapeutics, Inc.

Dynavax Technologies Corporation

Gyre Therapeutics, Inc.

Clearside Biomedical, Inc.

Additional Topics

Financing Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window